Principal Financial Group’s Lyell Immunopharma LYEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-550
Closed -$5.92K 2281
2025
Q1
$5.92K Hold
550
﹤0.01% 2166
2024
Q4
$7.04K Sell
550
-11
-2% -$218 ﹤0.01% 2206
2024
Q3
$15.5K Sell
561
-765
-58% -$22.5K ﹤0.01% 2214
2024
Q2
$38.4K Sell
1,326
-1,587
-54% -$75.6K ﹤0.01% 2304
2024
Q1
$130K Sell
2,913
-233
-7% -$9.98K ﹤0.01% 2245
2023
Q4
$122K Sell
3,146
-258
-8% -$9.29K ﹤0.01% 2239
2023
Q3
$100K Buy
3,404
+396
+13% +$18.8K ﹤0.01% 2282
2023
Q2
$191K Buy
3,008
+277
+10% +$15.3K ﹤0.01% 2192
2023
Q1
$129K Buy
2,731
+288
+12% +$15.4K ﹤0.01% 2258
2022
Q4
$170K Buy
2,443
+158
+7% +$15.7K ﹤0.01% 2224
2022
Q3
$335K Buy
2,285
+483
+27% +$65.4K ﹤0.01% 2052
2022
Q2
$235K Sell
1,802
-584
-24% -$59.7K ﹤0.01% 2252
2022
Q1
$241K Buy
2,386
+953
+67% +$115K ﹤0.01% 2294
2021
Q4
$222K Buy
+1,433
New +$320K ﹤0.01% 2331

Other funds holding LYEL